Understanding Addiction
Here's what science tells us about how addiction works and what helps.
How Addiction Works
The Reward System
Addictive substances hijack the brain's natural reward system[1]. The brain's dopamine system evolved to tag experiences as "worth repeating"—when you eat food or connect with friends, you get a small dopamine release. Drugs of abuse can create dopamine surges 2–10 times larger than natural rewards[2], essentially hijacking this system
Sugar activates reward circuits intensely—in rats, 94% preferred intense sweetness over cocaine[3]. The reward circuits respond intensely to concentrated sweetness, which may partly explain difficulties with sugar and processed food.
Tolerance and Withdrawal
With repeated use, the brain adapts[4]. The brain maintains balance (homeostasis), but when repeatedly flooded with a substance, it reduces its own production of similar chemicals and downregulates receptors:
- Tolerance: Increasing amounts of the drug are needed for the same effect, as neural circuits adapt to repeated exposure
- Dependence: The brain adjusts to expect the substance—stress and reward systems become dysregulated
- Withdrawal: When the substance is removed, the adaptations that compensated for the drug now create a deficit—causing physical and psychological symptoms until the brain readjusts
Craving
Craving is triggered by stress and environmental cues[5]. A meta-analysis of 237 studies found that exposure to drug-associated cues more than doubles the odds of subsequent drug use or relapse[6].
Environmental triggers include:
- Places associated with use
- People you used with
- Emotional states (stress, boredom, celebration)
- Sensory cues (smells, sounds, visuals)
These cues become conditioned through repeated pairing with substance use—the brain encodes them so that even after periods of abstinence, re-exposure can trigger strong cravings.
Behavioral Addictions
Addiction isn't limited to substances. Gaming addiction shows measurable brain changes[7].
Behavioral addictions share key features with substance addictions[8]:
- Compulsive engagement despite negative consequences
- Tolerance (need more to feel the same)
- Withdrawal symptoms when stopped
- Hijacking of reward pathways
Common behavioral addictions[9]:
- Gambling — formally recognized as an addictive disorder in both DSM-5 and ICD-11
- Internet/gaming — recognized by ICD-11; listed for further study in DSM-5
- Social media — emerging evidence of addiction-like symptoms, but no formal classification yet
- Shopping — growing data showing parallels to substance addictions, not yet formally recognized
- Compulsive sexual behavior — recognized as an impulse-control disorder in ICD-11, debated as an addiction
Is Addiction a "Brain Disease"?
The idea that addiction is a brain disease—championed by the U.S. National Institute on Drug Abuse (NIDA)—has been influential in shifting policy from punishment toward treatment. But the "brain disease model" is scientifically contested, and the debate matters for how we understand and treat addiction.
Arguments for the brain disease model:
- Addiction causes observable changes in brain structure and function, particularly in reward, motivation, and impulse-control regions
- Twin and family studies suggest roughly 50% of addiction risk is genetic[10]—not under voluntary control
- The chronic, relapsing nature of addiction resembles other chronic diseases like diabetes and hypertension
- The framing helped reduce stigma and increased access to medical treatment rather than criminal punishment
Arguments against (or questioning) the brain disease model:
- Most people with addiction eventually recover without formal treatment[11], suggesting more personal agency than is typical of diseases like Alzheimer's or cancer
- Brain changes from addiction are not unique—similar changes occur from intense learning, habits, and other experiences[12]
- The model can narrow focus to biology and neglect crucial psychosocial factors: trauma, poverty, social isolation, and environment[13]
- Some research suggests the brain disease label may actually lower self-efficacy in people trying to recover[14], potentially undermining a key ingredient for change
- The concept of "brain disease" lacks a clear, agreed-upon definition[15], making productive scientific debate difficult
Many researchers now advocate a biopsychosocial model that recognizes addiction involves brain changes, learned behaviors, social context, and individual agency[16]—not reducible to any single factor.
What Helps Recovery
Social Support
Changing social networks is crucial for recovery[17].
What helps:
- Support groups (AA, NA, SMART Recovery)[18] — a Cochrane review found AA/12-step programs produce higher abstinence rates than comparison treatments like CBT, with lower healthcare costs
- Rebuilding relationships with non-using friends and family
- Making new connections in recovery communities
- Peer support specialists who have lived experience[19] — systematic review found peer-delivered support improves treatment retention and recovery outcomes
Treatment Works
Treatment engagement reduces harm[20].
Effective treatments include:
- Medication[21]: For some addictions (opioids, alcohol, nicotine), medications can reduce cravings and ease withdrawal — a JAMA review of 118 trials confirmed medication effectiveness for alcohol use disorder
- Therapy[22]: CBT, motivational interviewing, contingency management — meta-analysis of 30 RCTs found CBT produces 15–26% better substance use outcomes vs. minimal treatment
- Support groups: 12-step programs, SMART Recovery
- Residential treatment[23]: For severe cases or when environment is triggering — systematic review found moderate evidence of effectiveness, best with integrated mental health care
Mindfulness and Attention Training
A systematic review of mindfulness-based programs for substance use disorders found they reduce cravings, decrease frequency and quantity of use, and improve co-occurring symptoms like anxiety and depression[24]. Mindfulness-Based Relapse Prevention (MBRP) — the most studied protocol — performs comparably to established therapies like CBT, and may be particularly effective for craving reduction and long-term relapse prevention.
Randomized trials confirm mindfulness training improves decision-making, inhibitory control, and reduces impulsivity[25] in people with substance use disorders. A related approach is cognitive bias modification — retraining the automatic attention and action tendencies that draw people toward substance-related cues. A multicenter RCT (169 participants) tested attentional bias modification training as an add-on to regular treatment for alcohol and cannabis use disorders[26], but found no significant differences in substance use, craving, or relapse at follow-up — suggesting this particular approach may not target the right cognitive mechanism. However, a different technique — approach-bias retraining, where patients practice pushing away alcohol-related images with a joystick — has shown more promise, with RCTs finding it reduces relapse rates by roughly 8–10% in the first year when added to standard treatment.
Recovery Narratives
Recovery stories share these common themes:
- Turning point: Recognizing the need to change
- New identity: Seeing oneself as a person in recovery
- Purpose: Finding meaning beyond substance use
- Connections: Rebuilding supportive relationships
- Ongoing growth: Viewing recovery as a journey, not a destination[27]
The Recovery Cascade
Williams et al. mapped a "cascade of care" for opioid use disorder[28] — borrowing the concept from HIV treatment — tracking how many people progress through each stage from identification to sustained recovery. They found large drop-offs at every step, showing that getting someone into treatment once is not enough.
Recovery is rarely linear. Most people:
- Try multiple times before achieving lasting recovery
- Benefit from multiple types of support simultaneously
- Need different things at different stages — early recovery may focus on medical stabilization, while later stages emphasize rebuilding social connections and purpose
Myths About Addiction
Reality: Initial use may be a choice, but addiction changes brain circuitry in ways that impair decision-making and impulse control.
Reality: Earlier intervention is more effective. Waiting for catastrophe causes unnecessary harm.
Reality: Relapse is common and doesn't erase progress. Rates are similar to other chronic diseases like diabetes.
Reality: Treatment, support systems, and often medication are far more effective than "just stopping."
Harm Reduction
Harm reduction accepts that some drug use will occur and focuses on minimizing negative consequences rather than requiring abstinence. Evidence consistently shows these approaches save lives without increasing drug use or crime rates[29].
- Syringe service programs (needle exchanges)[30]: A meta-analysis of 35 studies (56,000+ participants) found these programs reduce needle-sharing by 75% and are associated with 33–43% population-level reductions in HIV prevalence. They also serve as entry points for connecting people to treatment and other health services, and show no evidence of increasing drug use
- Medication-assisted treatment (MAT)[31]: A meta-analysis of 30 cohort studies (370,000+ participants) found overdose mortality drops from 2.43 to 0.24 per 100 person-years while receiving treatment — more than an 8-fold reduction. Methadone and buprenorphine are the most effective medications, and staying in treatment longer than one year further reduces risk
- Drug checking services[32]: Fentanyl test strips and other drug checking tools allow people to detect unexpected substances in their supply. A multisite study found that about 40–45% of people who detected fentanyl changed their behavior to reduce overdose risk — using smaller doses, going slower, not using alone, and keeping naloxone nearby
- Safe consumption sites[33]: No overdose death has ever occurred inside a legally sanctioned supervised consumption site worldwide, despite thousands of overdoses being reversed on premises. A systematic review found they also reduce infectious disease transmission, decrease public drug use and needle litter, and increase connection to addiction treatment services
---
References
- ['Badiani A', 'Belin D', 'Bhutton M', 'Drummond D', 'Robinson T'] (2007). The Mechanistic Classification of Addictive Drugs. PLOS Medicine. [DOI]
- Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F (2011). Addiction: Beyond dopamine reward circuitry. Proceedings of the National Academy of Sciences. [DOI]
- ['Lenoir M', 'Serre F', 'Cantin L', 'Ahmed SH'] (2007). Intense Sweetness Surpasses Cocaine Reward. PLOS ONE. [DOI]
- Koob GF, Volkow ND (2016). Neurobiology of addiction: a neurocircuitry analysis. The Lancet Psychiatry. [DOI]
- ['Nakagawa T', 'Kondo S', 'Takebayashi Y'] (2021). A mindfulness-based, stress and coping model of craving in methamphetamine users. PLOS ONE. [DOI]
- Vafaie N, Kober H (2022). Association of Drug Cues and Craving With Drug Use and Relapse: A Systematic Review and Meta-analysis. JAMA Psychiatry. [DOI]
- ['Yuan K', 'Cheng P', 'Dong T', 'Bi Y', 'Xing L', 'Yu D'] (2012). Cortical Thickness Abnormalities in Late Adolescence with Online Gaming Addiction. PLOS ONE. [DOI]
- Grant JE, Brewer JA, Potenza MN (2006). The neurobiology of substance and behavioral addictions. CNS Spectrums. [DOI]
- Potenza MN, Balodis IM, Derevensky J, Grant JE, Petry NM, Verdejo-Garcia A, Yip SW (2024). Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice. American Journal of Psychiatry. [DOI]
- Verweij KJH, Zietsch BP, Lynskey MT, Medland SE, Neale MC, Martin NG, Boomsma DI, Vink JM (2010). Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. Addiction. [DOI]
- Lopez-Quintero C, Hasin DS, de los Cobos JP, Pines A, Wang S, Grant BF, Blanco C (2011). Probability and predictors of remission from life-time nicotine, alcohol, cannabis, or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addiction. [DOI]
- Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ (2021). Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. [DOI]
- Blithikioti C, Nutt DJ, Munafò MR (2025). Reevaluating the brain disease model of addiction. The Lancet Psychiatry. [DOI]
- Wiers RW, Gladwin TE, Rinck M (2025). The compulsive brain disease model of addiction lowers self-efficacy. International Journal of Mental Health and Addiction. [DOI]
- Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ (2021). Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. [DOI]
- Blithikioti C, Nutt DJ, Munafò MR (2025). Reevaluating the brain disease model of addiction. The Lancet Psychiatry. [DOI]
- ['Kelly JF', 'Stout RL', 'Magill M', 'Tonigan JS', 'Pagano ME'] (2014). Young Adults, Social Networks, and Addiction Recovery: Post Treatment Changes in Social Ties and Their Role as a Mediator of 12-Step Participation. PLOS ONE. [DOI]
- Kelly JF, Humphreys K, Ferri M (2020). Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database of Systematic Reviews. [DOI]
- Bassuk EL, Hanson J, Greene RN, Richard M, Laudet A (2016). Peer-Delivered Recovery Support Services for Addictions in the United States: A Systematic Review. Journal of Substance Abuse Treatment. [DOI]
- ['Chang Z', 'Lichtenstein P', 'Långström N', 'Larsson H', 'Fazel S'] (2015). Mental Health Services and Public Safety: Substance Abuse Outpatient Visits Were Associated with Reduced Crime Rates in a Swedish Cohort. PLOS ONE. [DOI]
- McPheeters M, O'Connor EA, Riley S, Kennedy SM, Voisin C, Kuznacic K, Coffey CP, Edlund MD, Bobashev G, Jonas DE (2023). Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. JAMA. [DOI]
- Magill M, Ray L, Kiluk B, Hoadley A, Bernstein M, Tonigan JS, Carroll K (2019). A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. Journal of Consulting and Clinical Psychology. [DOI]
- de Andrade D, Elphinston RA, Quinn C, Allan J, Hides L (2019). The effectiveness of residential treatment services for individuals with substance use disorders: A systematic review. Drug and Alcohol Dependence. [DOI]
- Korecki JR, Schwebel FJ, Votaw VR, Witkiewitz K (2020). Mindfulness-based programs for substance use disorders: a systematic review of the evidence. Substance Abuse Treatment, Prevention, and Policy. [DOI]
- ['Kianersi S', 'Semnani Y', 'Nazari MA', 'Moulodi F'] (2023). The effect of mindfulness on decision-making, inhibitory control, and impulsivity of substance use disorder in-treatment patients: A randomized clinical trial. PLOS ONE. [DOI]
- ['Boffo M', 'Willemen L', 'Pronk T', 'Wiers RW'] (2021). Effectiveness of attentional bias modification training as add-on to regular treatment in alcohol and cannabis use disorder: A multicenter randomized control trial. PLOS ONE. [DOI]
- ['Parkman T', 'Lloyd C', 'Spilsbury K'] (2022). Characteristics of alcohol recovery narratives: Systematic review and narrative synthesis. PLOS ONE. [DOI]
- ['Williams AR', 'Nunes EV', 'Bisaga A', 'Levin FR', 'Olfson M'] (2019). Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment. PLOS Medicine. [DOI]
- Pridgen Bailey E, Bontemps AP, Lloyd AR, Wagner WP, Kay ES (2025). U.S. substance use harm reduction efforts: a review of the current state of policy, policy barriers, and evidence-based strategies. Harm Reduction Journal. [DOI]
- Various (2023). The Impact of Needle and Syringe Exchange Programs on HIV-Related Risk Behaviors and Outcomes in People Who Inject Drugs: A Systematic Review and Meta-Analysis. AIDS and Behavior. [DOI]
- Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, Degenhardt L, Farrell M, Blow FC, Ilgen M, Shi J, Lu L (2019). Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular Psychiatry. [DOI]
- Various (2025). Fentanyl Test Strip Use and Overdose Risk Reduction Behaviors Among People Who Use Drugs. JAMA Network Open. [DOI]
- Various (2021). Supervised Injection Facilities as Harm Reduction: A Systematic Review. American Journal of Preventive Medicine. [DOI]